What role can OCT angiography play in tracking the development of central serous retinopathy (CSR)? Yasha Modi, MD, and Kat Talcott, MD, review the use of OCT angiography in a real-world CSR case, discuss the value of selecting OCT angiography over fluorescein angiography for patients with neovascularization, and parse which populations are not a good fit for OCT angiography.
This episode is supported by Zeiss Professional Education.
Podden och tillhörande omslagsbild på den här sidan tillhör
Retina Today . Innehållet i podden är skapat av Retina Today och inte av,
eller tillsammans med, Poddtoppen.